ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,811,612 | -22.8% | 420,900 | -3.0% | 0.01% | -22.2% |
| Q2 2023 | $3,641,260 | -30.5% | 434,000 | -17.8% | 0.01% | -35.7% |
| Q1 2023 | $5,242,047 | +27.6% | 527,900 | -10.5% | 0.01% | +27.3% |
| Q4 2022 | $4,107,096 | -14.3% | 590,100 | -34.3% | 0.01% | -21.4% |
| Q3 2022 | $4,793,000 | +35.4% | 897,600 | +1.2% | 0.01% | +40.0% |
| Q2 2022 | $3,539,000 | +56.8% | 887,000 | +74.7% | 0.01% | +66.7% |
| Q1 2022 | $2,257,000 | -18.1% | 507,700 | -26.3% | 0.01% | -14.3% |
| Q4 2021 | $2,757,000 | -60.2% | 689,200 | -12.6% | 0.01% | -61.1% |
| Q3 2021 | $6,922,000 | -39.8% | 788,400 | -22.4% | 0.02% | -40.0% |
| Q2 2021 | $11,506,000 | +15.9% | 1,015,500 | +21.6% | 0.03% | +11.1% |
| Q1 2021 | $9,925,000 | +114.9% | 835,400 | +24.1% | 0.03% | +125.0% |
| Q4 2020 | $4,619,000 | +3.8% | 673,300 | +12.1% | 0.01% | -7.7% |
| Q3 2020 | $4,450,000 | +1286.3% | 600,600 | +680.0% | 0.01% | +1200.0% |
| Q2 2020 | $321,000 | +277.6% | 77,000 | +124.5% | 0.00% | – |
| Q1 2020 | $85,000 | +44.1% | 34,300 | +239.6% | 0.00% | – |
| Q4 2019 | $59,000 | – | 10,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |